You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of AGM use between two groups at different time points before and after surgery

From: Optimizing the sequential approach of combined phacoemulsification and gonioscopy-assisted transluminal trabeculotomy (GATT) in primary open-angle glaucoma

time

AGM(n, mean ± SD)

total

Phaco-GATT

GATT-Phaco

t

p

baseline

2.76 ± 0.62

2.68 ± 0.62

2.83 ± 0.62

-1.159

0.250

1 month

0.11 ± 0.31

0.15 ± 0.36

0.07 ± 0.26

1.133

0.261

3 month

0.30 ± 0.64

0.40 ± 0.74

0.21 ± 0.52

1.315

0.192

6 months

0.39 ± 0.78

0.50 ± 0.85

0.29 ± 0.71

1.245

0.217

12 months

0.48 ± 0.86

0.55 ± 0.88

0.40 ± 0.86

0.759

0.450

F

405.72

174.89

234.08

  

p

<0.001

<0.001

<0.001

  
  1. AGM = antiglaucoma medication; Phaco = phacoemulsification; GATT = gonioscopy‑assisted transluminal trabeculotomy. The P-values in the rightmost column represent the statistical comparisons of the Phaco-GATT and GATT-Phaco groups at each time point. The P-value in the last row represents the within-group comparison baseline with 12 months
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us